MPS1-HS
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Encapsulated Allogeneic MPS-1 Therapy (NCT05665036) | Sigilon Therapeutics, Inc. | 2021-11-15 |
Track MPS1-HS automatically
Every clearance here is in the API, with alerts when new ones post.